BILYPSA 4MG TABLET contains Saroglitazar which belongs to the group of medicines called Antidiabetic agents. It is indicated for the management of diabetic dyslipidaemia and hypertriglyceridemia (high levels of triglycerides) with Type 2 diabetes mellitus which is not controlled by statin therapy.
Diabetic Dyslipidaemia refers to a condition in which there are elevated triglycerides and LDL cholesterol, low HDL cholesterol, and major presence of small LDL particles. Your doctor may ask you to undergo certain diagnostic tests before starting the management with this medicine. Along with BILYPSA 4MG TABLET, your doctor might ask you to make certain lifestyle changes such as eating healthy, adequate sleep, weight and stress management, quitting smoking and alcohol.
BILYPSA 4MG TABLET should be used with caution in patients having liver, kidney or heart disease (with episodic congestive heart failure) and history of muscle diseases. BILYPSA 4MG TABLET should be used with caution in pregnant women and is not recommended for use in breast-feeding women.
Safety and effectiveness of this medicine has not been established in children, hence, ask for your doctor’s advice before taking. BILYPSA 4MG TABLET should be used with caution in elderly patients. The most common side effects of taking BILYPSA 4MG TABLET are gastritis, weakness, and fever. Consult your doctor if symptoms do not improve.
No content available
